Previous Article | Next Article ![]()
Applied and Environmental Microbiology, June 2005, p. 3199-3204, Vol. 71, No. 6
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.6.3199-3204.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Entomology, University of Kentucky, Lexington, Kentucky 40546
Received 27 September 2004/ Accepted 29 December 2004
|
|
|---|
|
|
|---|
The ability of Wolbachia to induce CI in its host has led to the proposal of strategies for controlling harmful insect populations. The strategies, including population replacement and population suppression (5), require the ability to generate novel Wolbachia-host associations via Wolbachia transfer (transfection). Transfection methods have also been used to facilitate studies of the Wolbachia-host interaction. For example, the interspecific transfer of Wolbachia between Drosophila simulans and Drosophila melanogaster has been used to demonstrate host effects on Wolbachia infection density and CI (3, 16).
Wolbachia transfection techniques have been developed for multiple insects including members of the orders Diptera, Lepidoptera, and Homoptera (3, 4, 9, 15-17). The methods used in the prior studies include the direct transfer of Wolbachia-infected embryonic cytoplasm and the transfer of infected embryo homogenate. With both techniques, the infected tissue is microinjected into the posterior end of early embryos, with a goal of infecting embryonic pole cells that will develop into germ tissues. Pole-cell infection is targeted, since this will develop into germ tissue and Wolbachia is maternally inherited. Thus, stable infection is thought to require that Wolbachia be established in the germ tissue that will develop into ovaries.
Although the transfer of embryonic cytoplasm is the most direct route for transfection, the use of homogenized embryos can be required for technical reasons including the physiology of donor embryos (4). For example, purification of Wolbachia following embryo homogenization can reduce complications associated with the microinjection of molecules and organelles from donor tissue that are detrimental to a distantly related recipient host. The use of homogenized tissue can allow the simultaneous transfer of multiple Wolbachia types by combining different insect tissues. Wolbachia enrichment from embryo homogenate can be used to facilitate transfection from small or weakly infected donor insects. Although microinjection of homogenized embryos can be technically advantageous and allows a broader application of Wolbachia transfection to include additional insect systems, its use has been limited in comparison with that of the cytoplasm transfer technique. Furthermore, there has not been a direct comparison of the two techniques for their transfection efficiencies (defined as the rates of establishing stable, maternally inherited Wolbachia infections).
A difference in transfection efficiency between the cytoplasm transfer and embryo homogenate transfer techniques can result from qualitative differences in the Wolbachia infections within the donor tissue. For example, all Wolbachia bacteria within an embryo may not be equally competent to establish germ line infection. A competency difference may result due to biological differences in Wolbachia or host factors. Injected polar plasm can form pole cells in the recipient embryos (8, 12, 14). An inability of Wolbachia to invade embryonic pole cells would limit transfection success to recipient embryos that were injected prior to pole-cell formation. In contrast, the injection of Wolbachia contained within pole plasm could subsequently form infected pole cells in the recipient that are derived from donor tissue. For Wolbachia in embryo homogenate, the buffer that provides the in vitro environment might play an important role in the maintenance of its infectivity, as has been found for Rickettsia (2).
Here we have compared the transfection efficiencies of Wolbachia bacteria originating from posterior and anterior cytoplasms. No difference was observed in the transfection success rates. Three buffers were compared by using homogenate injections. The results demonstrate an important effect of buffer type on transfection efficiency. Use of a sucrose-phosphate-glutamate solution (SPG buffer) resulted in a transfection success rate similar to that obtained using direct transfer of cytoplasm.
|
|
|---|
Embryo homogenization.
Three buffers were used for embryo homogenization: phosphate-buffered saline (PBS) (130 mM NaCl, 7 mM Na2HPO4 · 2H2O, 3 mM NaHPO4 · 2H2O, pH 7.0), Drosophila Ringer's buffer (182 mM KCl, 46 mM NaCl, 3 mM CaCl2, 10 mM Tris-HCl, pH 7.2), and SPG buffer (218 mM sucrose, 3.8 mM KH2PO4, 7.2 mM K2HPO4, and 4.9 mM L-glutamate, pH 7.2). The three buffers were selected because of their prior use in Wolbachia transfection with cell lines, Drosophila, and nematodes (4, 6, 10). For homogenization, approximately 30 µl of dechorionated eggs was rinsed with distilled water, transferred to a new tube, and rinsed with 0.5 ml buffer. Eggs were transferred into 1 ml fresh buffer in a Dounce tissue grinder (Fisher Scientific, Pittsburgh, PA) and briefly homogenized (
10 strokes at room temperature with the tight-fitting B-type pestle). The homogenate was transferred to a 1.5-ml tube and centrifuged at 300 x g for 5 min to remove large debris. The supernatant was transferred into a separate tube and centrifuged at 12,000 x g for 10 min to pellet the Wolbachia cells. The supernatant was removed, leaving a pellet in
50 µl, which was resuspended by pipetting. Debris was cleared from the suspension by centrifuging at 300 x g for 3 min. The supernatant was then transferred into a clean tube at 25°C until used for injection (<5 h).
Embryonic microinjection.
Wolbachia extract or embryo cytoplasm from Drosophila simulans (DSR) was microinjected into a DSRT embryo by standard techniques (3, 18). The needles (TW100F-4; World Precision Instruments, Inc., Sarasota, FL) were pulled using a micropipette puller (Model P-87; Sutter Instrument Co., Novato, CA). Injection was conducted with an IM 300 microinjector (Narishige Scientific Instrument Lab., Tokyo, Japan). For the posterior and anterior treatments, cytoplasm was withdrawn from donor embryos using the microinjector. Approximately 5% of the embryo cytoplasm was withdrawn from the posterior and anterior ends of the embryo (Fig. 1). Cytoplasm withdrawal was repeated sequentially with approximately 10 donor embryos and then immediately used to inject recipient DSRT embryos. Donor and recipient embryos were manipulated prior to pole-cell formation, which occurs
90 min after oviposition. The injection volume was determined empirically during injections. We assumed that the ideal injection volume would "reinflate" the desiccated recipient egg but not overpressurize the egg, which would result in significant cytoplasm outflow following needle removal. There was significant variation during injections due to differences in the desiccations of recipient eggs and slight variations in needle shape. After injection, slides with aligned embryos under oil were incubated at 21°C and 100% rH. Eggs were observed frequently so that hatching larvae could be quickly transferred onto instant Drosophila medium (Carolina Biological Supply Co., Burlington, NC). Subsequently, flies were moved to 25°C and reared as described above. Virgin females resulting from injected embryos (generation 0 [G0]) were isolated with four DSRT males to establish isofemale lines.
![]() View larger version (22K): [in a new window] |
FIG. 1. Wolbachia embryonic transfer experiments with different cytoplasms. Wolbachia bacteria from the posterior (A) and anterior (B) of donor embryos are injected to the posterior ends of recipient embryos.
|
PCR screening for infection status.
General wsp primers (81F/691R) were used for Wolbachia detection as previously described (22). Following the production of G1 pupae, G0 females were sacrificed for use in PCR assays. G0 females testing negative for Wolbachia infection were discarded along with their progeny. G0 males were PCR assayed for Wolbachia infection at the same time as the females. Following eclosion and mating, approximately 12 G1 females were isolated in media vials to establish isofemale lines. Following the production of G2 pupae, G1 females were assayed for Wolbachia infection using PCR. G1 females that tested negative for Wolbachia infection were discarded along with their progeny.
Cytoplasmic incompatibility crossing assays and statistical analysis.
Tests were performed at 25°C. Three virgin 5-day-old females were mated with two virgin 4-day-old males in a Drosophila medium vial for 2 days. Flies were then transferred into containers fitted with yeast-covered apple juice plates. After 24 h, the plates were removed. Egg hatch was assessed >36 h after oviposition. CI is calculated as the percentage of egg mortality. Statistical comparisons of infection status were conducted using chi-square or Fisher's exact tests, depending upon sample size. Kruskal-Wallis analysis was used in statistical comparisons of egg mortality levels (CI levels). All statistical comparisons were performed using SAS version 8.0 (SAS Institute, Cary, N.C.).
|
|
|---|
![]() View larger version (143K): [in a new window] |
FIG. 2. Cortical distribution of Wolbachia bacteria in the early DSR embryo that are used as donors for transfection. Top, DSRT; bottom, DSR. The posterior ends of the embryos are orientated toward the left.
|
|
View this table: [in a new window] |
TABLE 1. Wolbachia infection in the anterior and posterior treatments
|
As confirmation that PCR-positive transfected lines represent Wolbachia infections capable of inducing CI, crosses of transfected lines were used to determine CI levels in the G5 generation. The results are shown in Table 2. Low egg mortality (<16%) was observed in the compatible crosses (i.e., crosses of DSR females and the DSRT x DSRT cross). No difference in egg mortality was observed between the compatible crosses (Kruskal-Wallis; df = 5; P > 0.2). In contrast, more than 90% mortality resulted from crosses of uninfected DSRT females with the transfected males. The high egg mortality is similar to that observed in the incompatible cross between DSRT females and DSR males and is consistent with expectations of CI. Although the egg mortality was higher in crosses of DSRT females with transfected males relative to that in control crosses of DSRT females and DSR males, the difference was not significant (Kruskal-Wallis; df = 4; P > 0.06).
|
View this table: [in a new window] |
TABLE 2. CI level of transfected lines (G5)
|
|
View this table: [in a new window] |
TABLE 3. Survival rates from anterior and posterior treatments
|
|
View this table: [in a new window] |
TABLE 4. Wolbachia infection in different buffer treatments
|
|
View this table: [in a new window] |
TABLE 5. Survival rates with different buffer treatments
|
|
|
|---|
PCR-positive G1 individuals were consistently observed to transmit the Wolbachia infection to offspring. This has implications for subsequent transfection efforts. While intensive PCR screening is required in G0 and G1 to identify infected lines, we observed it to be unusual to lose the infection from infected G1 lines. Thus, screening efforts may be reduced following the recognition of G1-positive lines. In contrast, PCR-positive G0 females frequently resulted in uninfected G1 lines. Possible explanations could be that the G0 positives represent a PCR artifact (residual Wolbachia DNA), that G0 infection is limited to somatic tissue, or that ovaries are partially or weakly infected.
Although both anterior and posterior injections resulted in transfected lines, considerable variation was observed between replicate experiments (Table 1). A possible explanation for the variability includes variation in needle shape, which changes during injections due to small breaks. The volume of material injected also changes unpredictably due to clogging of the needle. Thus, constant adjustment is needed during sequential injections.
Comparison of anterior and posterior cytoplasm injections did not show a significant difference in Wolbachia transfection success (Table 1). However, interpretation is complicated by the experimental variability described in the preceding paragraph. Furthermore, the transfection efficiencies as defined in Tables 1 and 4 can be biased by the number of G1 isofemale lines obtained. For example, some G0 females produced fewer than seven G1 daughters. The number of replicate experiments described here is sufficient to detect obvious differences, such as the observed effect of buffer type. While an obvious difference between the anterior and posterior treatments was not observed, additional replicates might identify more subtle effects. For example, although not statistically significant, there is a trend for higher levels of vertical inheritance between G0 and G1 in the posterior treatments (G1 isofemale frequency; Table 1).
As a difference between the anterior and posterior treatments was not observed, we hypothesized that mixing anterior and posterior cytoplasms via embryo homogenization should not be detrimental to transfection efficiency. However, the preparation of embryo homogenate could reduce Wolbachia viability. Therefore, three homogenization buffers were examined for their effects on Wolbachia viability as measured by transfection efficiencies. The results demonstrate significant differences between the buffers, with SPG resulting in the highest transfection efficiency (69.2%). In contrast, embryo homogenization in PBS or Ringer's buffer leads to complete or partial loss of Wolbachia infectivity.
The SPG buffer used here was originally designed and optimized for Rickettsia (2). Thus, we hypothesized that the environment provided by SPG buffer would also be suitable to maintain Wolbachia in vitro because of similar metabolic properties shared by Rickettsia and Wolbachia (21). A possible reason for the success of the SPG buffer may be that glutamate is important for Wolbachia survival in vitro. Prior characterization of the wMel Wolbachia genome suggests that Wolbachia obtains much of its energy from amino acids (21). Limited carbohydrate metabolism in Wolbachia suggests that the sucrose in SPG may also be important to Wolbachia survival in vitro (21). The possibility that SPG buffer increases the infectivity of germ cells cannot be excluded.
The larval survival rate was significantly higher in the posterior treatment relative to that in the anterior treatment. This is likely due to differing cytoplasmic components. For example, bicoid and nanos occur along opposite gradients in embryos and are important in anterior and posterior development. Prior work shows that manipulation of the gradient via transfer of bicoid or nanos can corrupt normal development and result in mortality (7, 8). Thus, increased mortality in the anterior treatment may have resulted from misplaced morphogens in the embryo.
Wolbachia transfection between different invertebrate species, generating novel infection types, has been used to understand mechanisms of reproductive manipulations and other host-bacterium interactions. Furthermore, Wolbachia transfection is required for the applied strategies that use Wolbachia infections to affect populations of insect pests and disease vectors. Here we have demonstrated that Wolbachia bacteria from both anterior and posterior embryo cytoplasms are competent for establishing infection. Comparison also demonstrates that the SPG buffer provides an appropriate in vitro environment for Wolbachia, resulting in a transfection success rate comparable to that obtained by the direct transfer of infected embryonic cytoplasm. An ability to utilize homogenized embryos as a source of Wolbachia in transfections is expected to simplify future transfection attempts, especially with donor insects that are small or weakly infected.
We thank Subba Reddy Palli for assistance with fluorescence in situ hybridization, John Webb and Lok-Sze Cecilia for the help with injection, and Yan Xie for the statistical analysis.
This is publication 04-08-181 of the University of Kentucky Agricultural Experiment Station.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»